Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

Biotechnology
Chemicals
Food processing
Electronics
Healthcare
Pharmaceuticals

Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

Market segmentation
Competitive landscape
Regulatory policies
Latest technology trends
Acquisition evaluations
Vendors’ analysis, etc.

Publications found: 60,074

Sort by:

Phencyclidine (PCP) Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

This report is available by geographic region and country. Geographic Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealan...

September 2021 -

Phenobarbital Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Phenytoin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Phosphorus Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Potassium Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Prealbumin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Progesterone Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Prolactin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Propoxyphene Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Protein C Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Protein Electrophoresis Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Protein S Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Prothrombin Time (PT) Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

PTH/IO PT Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Quinidine Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Rivaroxaban Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Sirolimus Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Sodium Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

ST2 Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

T3 Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

T3 Uptake Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

T4 Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Tacrolimus Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

TBG Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Testosterone Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Theophylline Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Thrombin Time Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Thyroglobulin Ab Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Tobramycin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Topirimate Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Total Protein Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

TPO Ab Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Transferrin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Tricyclic Antidepressants Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Triglycerides Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Troponin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

TSH Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Uric Acid Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Valproic Acid Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Vancomycin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

Warfarin Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

US$ 4,850.00

September 2021 -

2021-2025 Albania Diagnostics Market Database: Shares and Forecasts for 500 Tests-Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

US$ 3,500.00

This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including volume and sales forecasts by test for the following market segments:Blood Banking...

September 2021 40 pages